Robert Bermel, MD
Additional Locations
Treatment & Services
- Consultation and Long-term Care
- Lumbar Puncture (Spinal Tap)
Specialty in Diseases & Conditions
- Acute Disseminated Encephalomyelitis (ADEM)
- Devic's Disease (Neuromyelitis Optica)
- Multiple Sclerosis
- Neuroimmunology
- Optic Neuritis
- Transverse Myelitis
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Robert Bermel, MD
Robert Bermel, MD is a Staff Neurologist in the Neurological Institute's Mellen Center for Multiple Sclerosis at Cleveland Clinic. He received a medical degree with thesis honors from the State University of New York at Buffalo, where his interest in MS began while training under Dr. Lawrence Jacobs. Dr. Bermel completed neurology residency training and served as Chief Resident at Cleveland Clinic. He was funded as a National MS Society postdoctoral fellow in clinical neuroimmunology and advanced imaging at Cleveland Clinic.
Dr. Bermel cares for patients, conducts imaging research, and participates in clinical trials at the Mellen Center. Dr. Bermel is leading the implementation and application of Optical Coherence Tomography (OCT) for the clinical program at the Mellen Center. His current research interests focus on the identification of advanced imaging methods to evaluate and improve recovery from inflammatory demyelinating disease. Specifically, he is utilizing techniques such as Optical Coherence Tomography (OCT), Diffusion Tensor MRI (DTI), and Functional MRI (fMRI). He is currently principal investigator on a research grant funded by the National MS Society, and a co-investigator on multiple clinical trials.
He regularly serves as a volunteer speaker to patient groups on behalf of the National MS Society, and occasionally as a consultant to industry in the field of MS therapeutics.
Education & Professional Highlights
Appointed
2008
Education & Fellowships
Fellowship - Cleveland Clinic
Neuroimmunology (Multiple Sclerosis)
Cleveland,
OH USA
2008
Residency - Cleveland Clinic
Neurology
Cleveland,
OH USA
2007
Internship - Cleveland Clinic
Internal Medicine
Cleveland,
OH USA
2004
Medical Education - State University of New York at Buffalo School of Medicine and Biomedical Scienc
Buffalo,
NY USA
2003
Undergraduate - State University of New York (SUNY) at Buffalo
Buffalo,
NY USA
1999
Professional Highlights
- National Multiple Sclerosis Society Research Grant: "Advanced imaging methods to study recovery from acute optic neuritis"
- Program Committee - American Society of Neuroimaging
- Regular volunteer speaker for the National Multiple Sclerosis Society
Certifications
- Psychiatry and Neurology - Neurology
Specialty Interests
clinical trial research, imaging research, Multiple Sclerosis, Neuroimmunology
Awards & Honors
- 2003 American Society of Neuroimaging William Oldendorf Award for Outstanding Neuroimaging Research. Presented at the ASN Annual Meeting, New Orleans, LA March 7, 2003 for the work entitled: "Gray matter T2 hypointensity predicts longitudinal brain atrophy in MS: effect of interferon beta-1a".
- 2003 American Academy of Neurology Medical Student Prize for Excellence in Neurology. Presented at University at Buffalo School of Medicine commencement May 23, 2003.
- 2003 State University of New York at Buffalo Baccelli Award for Most Outstanding Research. Presented at University at Buffalo School of Medicine commencement May 23, 2003.
- 2001 American Academy of Neurology G. Milton Shy Award in Clinical Neurology. Presented at the AAN Annual Meeting, Philadelphia, PA May 7, 2001 for the work entitled: "Bicaudate ratio as a marker of brain atrophy in multiple sclerosis".
Memberships
- American Academy of Neurology - member since 2000
- American Medical Association - member since 1999
- American Society of Neuroimaging - member since 2001. Annual Meeting Program Committee since 2003
Research & Publications
See publications for Robert Bermel, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 9/15/2022, Dr. Bermel has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Consulting and/or Speaking. Dr. Bermel receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:
- Sanofi Genzyme
- TG Therapeutics, Inc.
- AstraZeneca
- Laboratory Corporation of America Holdings
- Novartis International, AG
- Roche (Hoffman-La Roche, Ltd.)
Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Bermel may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:
- Qr8 Health, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
31 Patient Satisfaction Reviews
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.
| Overall | Star Ratings | |
|---|---|---|
| Explains | 4.9 | |
| Courtesy, Respect & Concern | 5 | |
| Patient Rating of Doctor | 4.9 |
9 Patient Comments
© 2022 The Cleveland Clinic Foundation. All Rights Reserved. No part of this work may be altered, reproduced, stored in a retrieval system, or transmitted, in any form, by any means, whether electronic, mechanical, by photocopying, recording, or otherwise, without the prior written permission of the Cleveland Clinic.
Reviewed on Nov 9, 2022
Dr. Bermel was very through and ordered test to get a definitive diagnosis.
Reviewed on Oct 18, 2022
I had a rather rare medical problem, but the dr.solved the problem when others could not.
Reviewed on Sep 29, 2022
I had a very good appointment with Dr. Bermel- he was very attentive, very interested in what I had to say about my condition.
Reviewed on Aug 29, 2022
Dr. Bermel was very knowledgeable and helpful.
Reviewed on Aug 24, 2022
Excellent service the Dr was friendly professional explained everything so very kind
Reviewed on Aug 17, 2022
Dr. Bermel is awesome. He always ensures I understand and has found time to fit me in.
Reviewed on Aug 17, 2022
Awesome Doctor. Very nice and polite. I never feel rushed.
Reviewed on Jul 13, 2022
I was extremely impressed with Dr. Bermel. He was kind, compassionate, and welcomed all questions. I didn't feel rushed during the visit and have since found that he really is ruling out every possible diagnosis to get to the right one. I am extremely pleased with the care I have received from him.
Reviewed on Jun 10, 2022
Dr. Bermel listened to my MS story. In 32+ years since I was diagnosed, neurologists in another city often "dismissed" me.